RTW Biotech Opportunities Operating

RTW Biotech Opportunities is a London-listed investment company (LSE: RTW/RTWG) focused on identifying and supporting transformative assets in the life sciences sector. Managed by RTW Investments, LP, the company invests in a diversified portfolio of private and public companies across various stages of development, from early-stage venture to late-stage clinical and commercial entities. Its strategy emphasizes deep scientific research to identify breakthrough therapies in areas such as genetic medicine, oncology, and rare diseases. In 2024, the company significantly expanded its portfolio through the strategic acquisition of Arix Bioscience. The fund provides public market investors with unique access to high-growth biotechnology innovations through a professionally managed vehicle.